A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

Clinical trial NCT07169851 · RECRUITING

Trial details

NCT number: NCT07169851
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Nausea Vomiting Drug-Related Side Effects and Adverse Reactions Neoplasms

Start date: 2025-11-28
Primary completion: 2026-12-01
Enrollment: 204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.